Delian Capital logo

Delian Capital

Asia, Beijing, China, Beijing

Description

Delian Capital specializes in the field of tech-driven industry such as high-end manufacturing, cutting-edge technologies, and healthcare.

Investor Profile

Delian Capital has backed more than 19 startups, with 4 new investments in the last 12 months alone. The firm has led 2 rounds, about 11% of its total and boasts 7 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States, Spain.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (32%)
  • Seed (26%)
  • Series C (16%)
  • Series B (11%)
  • Angel (5%)
  • Series Unknown (5%)
  • Series D (5%)

Country Focus

  • China (63%)
  • United States (26%)
  • Spain (5%)
  • France (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical
  • Artificial Intelligence (Ai)
  • Manufacturing
  • Medical Device
  • Cryptocurrency
  • Information Technology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Delian Capital frequently co-invest with?

AC Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
Loyal Valley Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Co-Stone Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 2
Virtus Inspire Ventures
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
AU21 Capital
North America, California, United States, San Francisco
Co-Investments: 2
LC
North America, Massachusetts, United States, Boston
Co-Investments: 1
Digital Finance Group (DFG)
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Oasis Capital
Africa, Greater Accra, Ghana, Accra
Co-Investments: 1
Chain Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1

Which angels does Delian Capital often collaborate with?

RS
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Delian Capital?

Neowise

Suzhou, Jiangsu, China

XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.

BiotechnologyHealth CarePharmaceutical
Series BJan 26, 2026
Amount Raised: $28,722,014
Lingke Medical

Hangzhou, Zhejiang, China

Lingke Medical a company specializing in intelligent temperature-controlled therapy technology

Artificial Intelligence (AI)Machine LearningMedical
Series ADec 15, 2025
Lingji Tianci Technology

Beijing, Beijing, China

Lingji Tianci is an innovative technology company focused on AI companionship.

Consumer ElectronicsEdTechEducation
SeedOct 9, 2025

Kangweijian Bio provides safe, high-quality raw materials for food, cosmetics, health, pharma, and animal nutrition worldwide.

Food and BeveragePersonal Health
Series BAug 29, 2025
VelaVigo

Shanghai, Shanghai, China

VelaVigo is a start-up company engaged in macromolecular biopharmaceutical.

BiopharmaBiotechnologyHealth CareTherapeutics
SeedJul 28, 2025
Amount Raised: $60,000,000
Green Carbon Synthesis

Shaoxing, Zhejiang, China

Green Carbon Synthesis is a process development company that produces green fuels and chemical raw materials.

BiofuelEnvironmental ConsultingGreenTech
SeedJul 21, 2025
Amount Raised: $13,929,129
Core Medical Technology

Shenzhen, Guangdong, China

Core Medical Technology develops ventricular assist devices and equipment.

ManufacturingMedicalMedical Device
Series DApr 24, 2025
Amount Raised: $100,000,000
X Square

Shenzhen, Guangdong, China

X Square is a company aiming to create a universal brain-cerebellum system for robots, encompassing capabilities from perception to action.

Artificial Intelligence (AI)Robotic Process Automation (RPA)Robotics
SeedNov 4, 2024
Amount Raised: $14,086,888
Juntong Future

Hangzhou, Zhejiang, China

Juntong Future is an artificial intelligence and digital intelligence security service provider.

Artificial Intelligence (AI)Security
SeedOct 16, 2024
PulseCare

Shenzhen, Guangdong, China

PulseCare is a medtech company that specializes in innovative medical devices and solutions for cardiac and pan-vascular treatment.

ManufacturingMedicalMedical Device
Series AAug 21, 2024
Amount Raised: $14,018,954

Find More Investors Like Delian Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides